313 related articles for article (PubMed ID: 15196864)
21. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
22. [Association between endogenous hormones, hormone receptors and cervical cancer].
Wang JT; Gao ES; Ding L; Cheng YY; Yan JW
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):494-7. PubMed ID: 17147111
[TBL] [Abstract][Full Text] [Related]
23. Female Sex Hormone Receptor Profiling in Uterine Adenosarcomas.
Marcus JZ; Klobocista M; Karabakhtsian RG; Prossnitz E; Goldberg GL; Huang GS
Int J Gynecol Cancer; 2018 Mar; 28(3):500-504. PubMed ID: 29303935
[TBL] [Abstract][Full Text] [Related]
24. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
[TBL] [Abstract][Full Text] [Related]
25. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical determination of hormone receptors in uterine adenosarcomas.
Amant F; Gabriel C; Moerman P; Vergote I
Gynecol Oncol; 2003 Mar; 88(3):463-4. PubMed ID: 12648606
[No Abstract] [Full Text] [Related]
27. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
[TBL] [Abstract][Full Text] [Related]
28. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
29. [Estrogen and progesterone receptors in corpus uteri carcinoma and their clinical significance].
Kleine W; Fuchs A; deGregorio G; Geyer H
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):884-7. PubMed ID: 6925560
[TBL] [Abstract][Full Text] [Related]
30. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
[TBL] [Abstract][Full Text] [Related]
31. Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components.
Taçkin S; Bozaci EA; Sönmezer M; Ekinci C; Ortaç F
Gynecol Oncol; 2006 Apr; 101(1):179-82. PubMed ID: 16325895
[TBL] [Abstract][Full Text] [Related]
32. Adenosarcoma of the uterine corpus associated with ovarian thecoma.
Nomura K; Aizawa S; Ushigome S
Pathol Int; 2001 Sep; 51(9):735-8. PubMed ID: 11696179
[TBL] [Abstract][Full Text] [Related]
33. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
Mann GB; Fahey VD; Feleppa F; Buchanan MR
J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
[TBL] [Abstract][Full Text] [Related]
34. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptors in endolymphatic stromal myosis.
Baker VV; Walton LA; Fowler WC; Currie JL
Obstet Gynecol; 1984 Mar; 63(3 Suppl):72S-74S. PubMed ID: 6700885
[TBL] [Abstract][Full Text] [Related]
36. Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term.
Turbiner J; Amin MB; Humphrey PA; Srigley JR; De Leval L; Radhakrishnan A; Oliva E
Am J Surg Pathol; 2007 Apr; 31(4):489-500. PubMed ID: 17414095
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
[TBL] [Abstract][Full Text] [Related]
38. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
39. Uterine adenosarcomas are mesenchymal neoplasms.
Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
[TBL] [Abstract][Full Text] [Related]
40. Significance of lymph node metastasis on survival of women with uterine adenosarcoma.
Machida H; Nathenson MJ; Takiuchi T; Adams CL; Garcia-Sayre J; Matsuo K
Gynecol Oncol; 2017 Mar; 144(3):524-530. PubMed ID: 28109626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
